IndraLab

Statements



sparser
"However, there are no reports on whether A20 can inhibit vascular smooth muscle cell proliferation in vivo."

reach
"The phenotype of this patient characterized by autoinflammation might be explained by increased cell proliferation and cell death caused by reduced TNFAIP3 (A20) expression."

eidos
"A20 inhibits cell proliferation and migration by downregulating glucose metabolism ."

reach
"TNFAIP3 overexpression strongly inhibited CRC proliferation, invasion, and migration."

sparser
"Here, we report that miR-125b is upregulated, whereas A20 is downregulated in NPC tissues relative to normal nasopharyngeal mucosa (NNM); miR-125b promotes NPC cell proliferation and inhibits NPC cell apoptosis by targeting A20/NF-κB signaling pathway; A20 inhibits NPC cell proliferation, induces NPC cell apoptosis, and reduces the growth of NPC xenograft tumors."

reach
"Results demonstrated that TNFAIP3 knockdown contributed to the proliferation, migration, invasion, and inflammation and suppressed the apoptosis in HAND2-AS1-overexpressed MH7A cells."

reach
"Importantly, TNFAIP3 knockout not only inhibited the AP20187 induced proliferation and tumor growth of DCIS-iFGFR1 cells, but also further reduced baseline proliferation and tumor growth of DCIS-iFGFR1 cells without AP20187 treatment."

sparser
"Subsequent analysis has revealed that not only does A20 inhibits cell proliferation, but it has also been linked to the increased angiogenesis [ xref , xref ]."

eidos
"Like CYLD , A20 suppresses cell proliferation and promotes apoptosis as a negative regulator of the NF-kappaB pathway , and it is well known to play an important role in inflammation and immunity ( Dixit et al. 1990 ; Hoesel and Schmid 2013 ) ."

eidos
"A20 knockdown enhanced cell proliferation , clone formation , and migration , while A20 overexpression suppressed these capacities in HCC cells , both in vitro and in vivo ( Fig. 1a-d and Supplementary Fig. S1b ) ."

reach
"Furthermore, we revealed that TNFAIP3 overexpression inhibited CRC cell proliferation, invasion, and migration."

reach
"In addition, TNFAIP3 re-expression can inhibit proliferation, decrease expression of target genes in NF-kappaB signaling pathway, increase cytotoxicity and induce apoptosis in cells lacking TNFAIP3."

eidos
"A20 Like CYLD , A20 suppresses cell proliferation and promotes apoptosis as a negative regulator of the NF-kappaB pathway , and it is well known to play an important role in inflammation and immunity ( Dixit et al. 1990 ; Hoesel and Schmid 2013 ) ."

sparser
"With a combination of loss-of-function and gain-of-function approaches, we further showed that A20 inhibited NPC cell proliferation, induced NPC cell apoptosis, and reduced the growth of NPC xenograft tumors."

sparser
"A20 inhibits SMC proliferation via increased expression of cyclin-dependent kinase inhibitors p21waf1 and p27kip1."

reach
"Furthermore, KO of TNFAIP3 inhibited cell proliferation when compared with their parent control cells in the absence of AP20187 treatment, suggesting that TNFAIP3 may also be required for the endogenous FGFR1-mediated cell growth or involved in other cell growth pathways."

sparser
"A20 could also promote liver regeneration [ xref ] and inhibit HCC proliferation, metastasis and microvascular invasions [ xref , xref ]."

eidos
"A20 inhibits cell proliferation and migration by downregulating glucose metabolism Aerobic glycolysis promotes tumor cell proliferation and migration ."

sparser
"In summary, our data demonstrate that miR-125b is frequently upregulated in the NPC biopsies, and is an independent predictor for NPC patient survival; miR-125b regulates NPC cell proliferation and apoptosis by targeting A20/NF- κ B signaling pathway; A20 inhibits NPC cell proliferation and induces NPC cell apoptosis both in vitro and growth i n vivo ."

sparser
"A20 Inhibited Proliferation, Migration, and Lipopolysaccharide-Induced Inflammation of SMCs via Increasing PPARα Expression."

reach
"In summary, we identified that SFE inactivated the NFkappaB pathway and down-regulated TNFAIP3 and PLAU expression to suppress ESCC cell proliferation and metastasis, providing new insights into the anticarcinogenic activity of SFE and confirming SFE as a potential chemotherapeutic agent."